After propensity score matching (18,386 patients), researchers found: Patients receiving tirzepatide were 1.76 times more likely to achieve 5% weight loss 2.54 times more likely to achieve 10% weight loss 3.24 times more likely to achieve 15% weight loss At 12 months, the difference in weight change was 6.9 percentage points favoring tirzepatide
GHK-Cu reduces inflammatory cytokines and oxidative stress, creating a healthier environment for regrowth
The weight of evidence supports a role in dementia risk reduction, particularly among individuals with diabetes, obesity, metabolic syndrome, or APOE 4 risk
Apoptosis and glutathione: beyond an antioxidant
This aligns with the body's natural endocrine rhythms and provides a full day of elevated IGF-1 levels to support recovery and growth processes throughout the subject's active period
This combination makes yoga particularly helpful if high-intensity exercise feels overwhelming or triggers your anxiety